Key result
Helium preconditioning reduced myocardial infarct size compared with control, an effect mediated by nitric oxide.
Why the study?
Does helium-induced preconditioning reduce myocardial infarct size in rabbits subjected to ischemia-reperfusion?
Does helium-induced preconditioning reduce myocardial infarct size in rabbits subjected to ischemia-reperfusion?
Helium-induced cardioprotection against ischemia-reperfusion injury in rabbits is mediated by nitric oxide, likely generated by endothelial NOS.
Answers are grounded in this paper and cite their sources.
Does not support clinical use; leaves open translation of helium preconditioning to human ischemia-reperfusion injury.
In Brief BACKGROUND: Helium produces preconditioning against myocardial infarction by activating prosurvival signaling, but whether nitric oxide (NO) generated by endothelial NO synthase plays a role in this phenomenon is unknown. We tested the hypothesis that NO mediates helium-induced cardioprotection in vivo. METHODS: Rabbits (n = 62) instrumented for hemodynamic measurement were subjected to a 30-min left anterior descending coronary artery occlusion and 3 h reperfusion, and received 0.9% saline (control) or three cycles of 70% helium–30% oxygen administered for 5 min interspersed with 5 min of an air–oxygen mixture before left anterior descending coronary artery occlusion in the absence or presence of pretreatment with the nonselective NOS inhibitor N-nitro-l-arginine methyl ester (L-NAME; 10 mg/kg), the selective inducible NOS inhibitor aminoguanidine hydrochloride (AG; 300 mg/kg), or selective neuronal NOS inhibitor 7-nitroindazole (7-NI; 50 mg/kg). In additional rabbits, the fluorescent probe 4,5-diaminofluroscein diacetate (DAF-2DA) and confocal laser microscopy were used to detect NO production in the absence or presence of helium with or without L-NAME pretreatment. RESULTS: Helium reduced (P < 0.05) infarct size (24% ± 4% of the left ventricular area at risk; mean ± sd) compared with control (46% ± 3%). L-NAME, AG, and 7-NI did not alter myocardial infarct size when administered alone. L-NAME, but not 7-NI or AG, abolished helium-induced cardioprotection. Helium enhanced DAF-2DA fluorescence compared with control (26 ± 8 vs 15 ± 5 U, respectively). Pretreatment with L-NAME abolished these helium-induced increases in DAF-2DA fluorescence. CONCLUSIONS: The results indicate that cardioprotection by helium is mediated by NO that is probably generated by endothelial NOS in vivo. IMPLICATIONS: Brief, repetitive administration of the nonanesthetic noble gas helium before prolonged coronary artery occlusion and reperfusion reduced myocardial infarct size in rabbits by a nitric oxide (NO)-mediated mechanism. Helium directly increased NO production as detected using 4,5-diaminofluroscein diacetate staining independent of ischemia and reperfusion.
No takes yet. Share an insight, caveat, or question.
Pagel et al. (2008) studied Myocardial infarction (n=62). Helium (70% helium-30% oxygen) vs. 0.9% saline (control) was evaluated on Infarct size (% of the left ventricular area at risk) (p=< 0.05). Helium preconditioning reduced myocardial infarct size compared with control, an effect mediated by nitric oxide.
Synapse has enriched 10 related papers. Consider them for comparative context: